<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Trinidad and Tobago</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Trinidad and Tobago.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/tt.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Sat, 07 Nov 2026 03:45:11 GMT</lastBuildDate>
  <item>
    <title>Acute-phase clinical profile and quality of life in patients with chikungunya during the 2025 outbreak in Bangladesh: A facility-based cross-sectional study</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014599-89df8f05/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014599-89df8f05/</guid>
    <pubDate>Wed, 26 Aug 2026 00:00:00 GMT</pubDate>
    <description>The outbreak placed a measurable burden on facilities and markedly reduced patient quality of life, with women disproportionately affected.</description>
    <category>Chikungunya</category>
    <category>Outbreak investigation</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Direct and Indirect Estimates of HIV-1 Incidence in a High-Prevalence Population</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1093-oxfordjournals-aje-a009536-4fb43cb8/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1093-oxfordjournals-aje-a009536-4fb43cb8/</guid>
    <pubDate>Fri, 01 May 1998 00:00:00 GMT</pubDate>
    <description>The abstract frames reliable HIV-1 incidence estimation as important where direct incidence data are hard to obtain and prevalence is rising in heterosexually exposed populations. It also states that approximate incidence measures may support health planning, evaluation, and preliminary assessment of populations for vaccine efficacy trials.</description>
    <category>AIDS</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Cohort study</category>
  </item>
</channel>
</rss>
